[HTML][HTML] Cannabis hyperemesis syndrome: an update on the pathophysiology and management

A Perisetti, M Gajendran, CS Dasari… - Annals of …, 2020 - ncbi.nlm.nih.gov
Cannabis hyperemesis syndrome (CHS) is a form of functional gut-brain axis disorder
characterized by bouts of episodic nausea and vomiting worsened by cannabis intake. It is …

Endocannabinoid signaling in stress, nausea, and vomiting

MV DeVuono, T Venkatesan… - Neurogastroenterology & …, 2024 - Wiley Online Library
Background Classical antiemetics that target the serotonin system may not be effective in
treating certain nausea and vomiting conditions like cyclic vomiting syndrome (CVS) and …

Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence

CN Andrews, R Rehak, M Woo, I Walker… - Alimentary …, 2022 - Wiley Online Library
Background Cannabinoid hyperemesis syndrome (CHS) is a poorly understood vomiting
disorder associated with chronic cannabis use. Aims To characterise patients experiencing …

Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature

G Burillo-Putze, JR Richards… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Cannabinoid hyperemesis syndrome (CHS) is an uncommon but unique
disorder defined by recurrent abdominal pain, intractable nausea, and emesis in patients …

Role of cannabis and its derivatives in gastrointestinal and hepatic disease

J Gotfried, T Naftali, R Schey - Gastroenterology, 2020 - Elsevier
Medical and recreational cannabis use has increased dramatically over the last decade,
resulting from mainstream cultural acceptance and legalization in several countries …

Cyclic vomiting syndrome in children

U Raucci, O Borrelli, G Di Nardo, R Tambucci… - Frontiers in …, 2020 - frontiersin.org
Cyclic Vomiting Syndrome (CVS) is an underdiagnosed episodic syndrome characterized by
frequent hospitalizations, multiple comorbidities, and poor quality of life. It is often …

Cannabinoids and the gastrointestinal tract

M Camilleri, T Zheng - Clinical Gastroenterology and Hepatology, 2023 - Elsevier
The synthesis and degradation of endocannabinoids, location of cannabinoid (CB)
receptors, and cannabinoid mechanisms of action on immune/inflammatory, neuromuscular …

Cannabis and cannabinoids in adults with cancer: ASCO guideline

IM Braun, K Bohlke, DI Abrams, H Anderson… - Journal of Clinical …, 2024 - ascopubs.org
PURPOSE To guide clinicians, adults with cancer, caregivers, researchers, and oncology
institutions on the medical use of cannabis and cannabinoids, including synthetic …

The childhood migraine syndrome

I Abu-Arafeh, AA Gelfand - Nature Reviews Neurology, 2021 - nature.com
Migraine is a complex genetic brain disorder with an intricate pathogenesis and
polymorphous clinical presentations, particularly in children. In this Perspective, we describe …

Pharmacology, clinical effects, and therapeutic potential of cannabinoids for gastrointestinal and liver diseases

DB Maselli, M Camilleri - Clinical Gastroenterology and Hepatology, 2021 - Elsevier
Cannabis and cannabinoids (such as tetrahydrocannabinol and cannabidiol) are frequently
used to relieve gastrointestinal symptoms. Cannabinoids have effects on the immune system …